Health Care & Life Sciences » Biotechnology | Dynavax Technologies Corp.

Dynavax Technologies Corp.

Dynavax Technologies Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
62.62 M
Public Float
61.1 M
Dynavax Technologies Corp.
Stock Exchange NASDAQ Stock Market
EPS
$2.54
Market Cap
$259.61 M
Shares Outstanding
65.06 M
Public Float
62 M

Profile

Address
2929 Seventh Street
Berkeley California 94710
United States
Employees -
Website http://www.dynavax.com
Updated 07/08/2019
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases.

Financials

View All
Created with Highcharts 5.0.14Dynavax Technologies Corp.Net Income. Fiscal year is January-December. All values USD Thousands.66 72066 72090 72290 722106 794106 794112 444112 44495 15495 154158 899158 899201320142015201620172018050k100k150k200k
Created with Highcharts 5.0.14Dynavax Technologies Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.11 25111 25111 03211 0324 0504 05011 04311 0433273278 1988 19820132014201520162017201802.5k5k7.5k10k12.5k

Arnold Lewis Oronsky
Chairman
Eddie J. Gray
Chief Executive Officer & Director